Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747838 · ClinicalTrials.gov registry record
A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias
A clinical trial, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- 106
- Enrollment target
NCT00747838: Clinical Trial study, sponsored by Virginia Commonwealth University.
NCT00747838 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747838 was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Minimally invasive surgical treatment of atrial fibrillation is safe and effective at controlling atrial fibrillation. The fundamental goal of STAR Outcomes registry is to improve the understanding of the efficacy of surgical ablation intervention in the treatment of atrial fibrillation.
Interventions
- PROCEDURE Minimally Invasive Maze Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2008-09 |
| Est. Completion | 2012-12 |
Why NCT00747838 stopped before completion
NCT00747838 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Minimally Invasive Maze Procedure is the first listed.
NCT00747838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00747838 about?
NCT00747838 is a clinical study titled "A Multicenter Data Registry for Outcomes From Surgical Treatment of Atrial Arrhythmias". Minimally invasive surgical treatment of atrial fibrillation is safe and effective at controlling atrial fibrillation. The fundamental goal of STAR Outcomes registry is to improve the understanding of the efficacy of surgical ablation intervention in the treatment of atrial fibrillation.
What is the current status of trial NCT00747838?
This trial is currently terminated. The enrollment target is 106 participants. The study started on 2008-09. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00747838?
The interventions under investigation include: Minimally Invasive Maze Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT00747838?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia